Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Drug manufacturing

EMA tells drug manufacturers to test for probable carcinogen

The European Medicines Agency (EMA) has told drug manufacturers to test all medicines that contain chemically synthesised active substances to test for the presence of nitrosamines.

The EMA’s human medicines committee said in a press release on 26 September 2019 that it was requesting marketing authorisation holders for human medicines to “test all products at risk … as a matter of precaution”.

If nitrosamines are detected in any of their medicines, manufacturers must inform authorities promptly, the EMA said. A notice has been sent to drug manufacturers providing information on risk evaluation, confirmatory testing, and any changes they may need to request to the marketing authorisation.

Nitrosamines are classified as probable carcinogens, although the EMA said that when they have been found in medicines the risk of developing cancer has been low.

In 2018, nitrosamines and another probable carcinogen, N-nitrosodimethylamine (NDMA), were found in several sartan blood pressure medicines, leading to recalls and an EU review which set strict new manufacturing requirements for these medicines.

Then, in September 2019, the EMA announced that it was beginning a review of ranitidine medicines after tests revealed the presence of NDMA.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20207136

Readers' comments (1)

  • Nitrosamines (or their precursor) are reputedly present in nitrate/nitrite cured meats. Perhaps they'll be made illegal soon.

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now
  • English Delftware Drug Jars

    English Delftware Drug Jars

    This beautiful book illustrates the art and history of the collection of English delftware drug jars in the Museum of the Royal Pharmaceutical Society of Great Britain.

    £54.00Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.